Find clinical trials for Breast Cancer in Louisville, KY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Louisville, KY, USA:
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Louisville, Kentucky, United States and 226 other locations
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Louisville, Kentucky, United States and 57 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Louisville, Kentucky, United States and 32 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Louisville, Kentucky, United States and 324 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Louisville, Kentucky, United States and 50 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Louisville, Kentucky, United States and 147 other locations
Some human epidermal growth factor receptor 2 (HER-2) breast cancer patients do not respond or become resistant to current treatmen...
Phase 2
Louisville, Kentucky, United States and 98 other locations
This research study is studying three combinations of drugs as treatments for breast cancer.The drugs involved in this study are:Fu...
Phase 2
Louisville, Kentucky, United States and 21 other locations
of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple negative breast...
Phase 2
Louisville, Kentucky, United States and 23 other locations
versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer subjects previously treated with trastuzumab and taxane....
Phase 3
Louisville, Kentucky, United States and 163 other locations
Clinical trials
Research sites
Resources
Legal